The global periodontal market size is expected to enjoy a valuation of US$ 9.1 billion in the year 2022, and further expand at a CAGR rate of 10.4% to reach a valuation of ~US$ 24.4 billion by the year 2032. According to a recent study by Future Market Insights, device type in the product segment is leading the market with a share of about 77.6% in the year 2021, within the global market.
Market Outlook:
Data Points | Market Insights |
---|---|
Market Value 2022 | US$ 9.1 billion |
Market Value 2032 | US$ 24.4 billion |
CAGR 2022 to 2032 | 10.4% |
Market Share of Top 5 Countries | 55.4% |
Key Market Players | Dentsply Sirona, 3M Company, Danaher Corporation (Sybron Dental Specialties Inc./Kerr Corporation), Medtronic, Pfizer Inc., Novartis AG, ASA Dental S.p.A., Steris-Hu-Friedy, Carl Martin GmBH, Deppeler SA, AMD Lasers, Inc., Biolase, Inc., Straumann AG, Planmeca Oy, Karl Schumacher, GC Corporation, OraVu®, Micron Dental, and DENTAURUM GmbH & Co. KG |
The growth of the periodontal market is very much inclined to the prevalence of periodontal diseases, which is constantly rising. Periodontal diseases or gum diseases are disorders that occur due to the infection and inflammation of mainly the gums and bone surrounding the teeth.
As per findings from the Centers for Disease Control and Prevention, 47.2% of people who are 30 years old and above, encounter some form of periodontal disease in the USA The prevalence of these diseases increases with natural aging. It has been estimated that 70.1% of the geriatric population who are 65 years and above are suffering from gum diseases in the USA
Since the prevalence of periodontal diseases is pretty high, therefore the adoption of the different devices used in the diagnosis, treatment, and surgery of periodontal diseases is quite high. Also, the recommendation of the drugs like antibiotics is rising in the same field. This is quite advantageous for the growth of the periodontal market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value of the periodontal market was approximately 24.2% of the overall ~US$ 34.2 billion of the global dental market in 2021.
The sale of the periodontal market expanded at a CAGR of 8.8% from 2015 to 2021. According to the WHO, age is the primary risk factor for the development of dental diseases and the risk for dental disorders increases with age, particularly for people aged >50 years. Hence, the rising geriatric population is one of the major drivers of the periodontal market.
As per the findings from WHO, the percentage of the population of people who are 60 years of age and above would nearly double in a time span of 35 years. It would increase from 12% to 22% between 2015 and 2050. This would positively impact the growth of the periodontal market.
Other than this, technological advancements can be considered a recognizable driver for this market. The shift from invasive techniques used for a root canal, crown troughing, implant recovery, gingivoplasty, and many more dental procedures towards advanced laser techniques such as diode lasers and CO2 lasers is also expected to contribute to the acceleration of the growth of this market, owing to the prevention of the oral infections. When it comes to periodontal disease diagnosis, 3D digital X-ray imaging is quite commonly used.
Thus, owing to the forenamed factors, the global periodontal market is expected to grow at a CAGR rate value of 10.4 % during the forecast period from 2022 to 2032.
The market is set to have an assertive outlook, owing to the increased regulatory approvals for the products used in the periodontal market. Regulatory bodies like FDA regulate the approval of the medical devices being launched in the USA market.
Apart from this, drug approval is also governed by the FDA so that, it can be proved that the new drug is safe and effective for the patients. The introduction of novel products aligns with the entry of new and improved technology in the market, which ensures the enhancement and launch of new products in the market. This helps bring in new technology that eases treatment procedures and provides improved results to patients. This can be considered an opportunistic factor for the manufacturers operating within the periodontal market.
The cost linked with dental treatments and diagnostic procedures is quite high. The cost of treating periodontal disease can range from $1,700 to $8,000, depending on the severity level of the disease. These high costs along with the low reimbursement rate for dental procedures are the factors that can hamper the growth of the periodontal market.
Apart from this, the shortage of dental professionals in developing countries can be a major restraining factor for this market. As per a research article published by NCBI in 2021, a shortfall of dentists and specialists in South Africa is predicted till 2030. It was reported that in an ideal scenario, there would be a shortage of 853 dentists and specialists in 2018, 1655 in 2024, and 2267 in 2030.
The mentioned factors collectively propose an adverse effect on the developmental growth of the periodontal market.
The USA dominates the North American region with a total market share of about 92.8% in 2021, and a similar trend is expected over the forecast period.
In the USA, October has been celebrated as National Dental Hygiene Month since 2009 as per the American Dental Hygienists’ Association. This has been initiated to increase awareness about oral heath so that, the general public can be aware of the risks that they can be prone to if they do not follow good oral habits. This would further increase the adoption of effective procedures for the treatment and diagnosis of periodontal diseases. Hence, the sales of periodontal treatment product including both drugs and devices in the USA is quite high and is anticipated to grow moving forward.
The presence of multiple manufacturers like Dentsply Sirona, AMD Lasers, Inc., BIOLASE, Inc., Karl Schumacher, and others is quite high in the USA market and this has boosted the availability of products in the USA periodontal market.
United Kingdom is set to exhibit a CAGR growth rate of nearly 11.0% in the European periodontal market during the forecast period. In 2021, the United Kingdom held the highest market share of about 24.9% of 2021 the Europe periodontal market.
As per recent data from the Department of Health and Social Care, almost half of the adults in the United Kingdom get affected by irreversible periodontitis. This points to the high prevalence of periodontal diseases in the United Kingdom, hence, the periodontal market in the United Kingdom is quite lucrative.
India held approximately 45.2% market share in the South Asia periodontal market in 2021. It is projected to display growth at a lucrative CAGR rate of 11.1% during the forecast period.
The use of tobacco is very common in a country like India. As per a recent publication from the National Center for Biotechnology Information in 2021, the most significant risk factor for periodontal disease is tobacco smoking, since it worsens the condition and raises the risk of periodontal surgery. By inducing microvascular dysfunction, tobacco use harms the vasculature and is known to have a deleterious impact on periodontal health.
As per the Global Adult Tobacco Survey India, 2016 to 17, nearly 29% of all adults who are 15 years old and above are tobacco users. This data has been highlighted by the WHO as well. This scenario has contributed to the propelling growth of the periodontal market in India.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The device segment in the product category of the periodontal market is expected to present high growth at a CAGR rate of 11.3% by the end of the forecast period, with a projected market share of about 84.8% in the global market in 2032. Since the usage of either diagnostic, treatment or surgical instruments is more compared to the consumption of drugs in the periodontology field of dentistry, the device segment is significantly dominant in the product category.
Scaling and root planning accounted for a revenue share of 36.1% in 2021 and are expected to display gradual growth over the forecast period. Scaling and root planing procedures are counted as non-surgical therapies for removing the infection above or below the gum line. Depending on the severity of the infection, the number of sessions is decided for scaling and root planning.
Dental Clinics held the highest market share of 57.4% during the year 2021. The increasing number of clinics specific to the field of dentistry is a major factor due to which dental clinics have been estimated to account for more than half of the share of the end-user segment in the forecast period as well.
To strengthen their presence around the globe and improve their business strategies, the key players are involved in various product launches, expansions, collaborations, and mergers and acquisitions. These are the top key promotional strategies adopted by the key players in the periodontal market.
Attribute | Details |
---|---|
Forecast Period | 2022 to 2032 |
Historical Data Available for | 2015 to 2021 |
Market Analysis | US$ million for Value |
Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, The United Kingdom, Germany, Italy, France, Spain, Russia, BENELUX, Nordic Countries, India, Malaysia, Thailand, Indonesia, China, Japan, South Korea, Australia, New Zealand, Turkey, GCC, and South Africa |
Key Market Segments Covered | Product, Procedures, End User, and Region |
Key Companies Profiled |
|
The global periodontal market is estimated to be worth US$ 9.1 billion in 2022.
The periodontal market is expected to reach US$ 24.4 billion by end of 2032 at a CAGR of 10.4%.
Growing awareness regarding oral hygiene, rising medical and dental tourism and consideration of non-surgical periodontal therapy are some of the key trends in this market.
North America dominated the global periodontal market accounting for the highest market share of 34.4% in 2021
United Kingdom displays a market share of around 24.9% in 2021 in the Europe periodontal market and is set to present a lucrative CAGR growth rate of 11.0% during the forecasted years.
India accounts for about 45.2% of the market share of the South Asian periodontal market in 2021 and is projected to grow with a CAGR of 11.1% in the forecast period.
USA., United Kingdom, Germany, India and China are the top five countries, which are expected to drive demand in the periodontal market.
From 2015 to 2021, the market for periodontal expanded at the rate of 8.8%.
China accounted for over 43% market share of the East Asia periodontal market in 2021. The periodontal market in China is expected to grow at 10.4% CAGR value during the forecast period.
Germany held a market share of nearly 22% of the Europe periodontal market in 2021 and is set to present a lucrative CAGR growth rate of 10.3% during the forecast period.
1. Executive Summary | Periodontal Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Product Adoption / Usage Analysis 4.2. Product USP Analysis 4.3. Key Strategies Adopted by Manufacturers 4.4. Value Chain Analysis 4.5. PESTLE Analysis 4.6. Porter’s Analysis 4.7. Regulatory Scenario 4.8. Pipeline Assessment 5. Global Market Demand in Volume (Units) Analysis 2015 to 2021 and Forecast, 2022 to 2032 5.1. Historical Market Volume (Units) Analysis, 2015 to 2021 5.2. Current and Future Market Volume (Units) Projections, 2022 to 2032 5.2.1. Y-o-Y Growth Trend Analysis 6. Global Market - Pricing Analysis 6.1. Regional Pricing Analysis, By Product 6.2. Global Average Pricing Analysis Benchmark 7. Global Market Demand (in Value or Size in US$ million) Analysis 2015 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Value (US$ million) Analysis, 2015 to 2021 7.2. Current and Future Market Value (US$ million) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Market Background 8.1. Macro-Economic Factors 8.1.1. Global GDP Growth Outlook 8.1.2. Global Healthcare Industry Market Outlook 8.2. Forecast Factors - Relevance & Impact 8.2.1. Rising demand for Dental Care 8.2.2. Prevalence of Oral Diseases 8.2.3. Growing Investment in Healthcare Expenditures 8.2.4. Advancement and development in Technology 8.2.5. Cost of the products 8.2.6. Increased Pipeline products 8.2.7. Increasing Adoption of Automated Equipment 8.3. Market Dynamics 8.3.1. Drivers 8.3.2. Restraints 8.3.3. Opportunity Analysis 9. COVID-19 Crisis - Impact Assessment 9.1. Current COVID-19 Statistics and Probable Future Impact 9.2. Current GDP Projection and Probable Impact 9.3. COVID-19 and Impact Analysis 9.4. 2021 Market Scenario 9.4.1. By Product 9.4.2. By Procedures 9.4.3. By End User 9.4.4. By Region 10. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ million) and Volume (Units) Analysis, By Product, 2015 to 2021 10.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Product, 2022 to 2032 10.3.1. Devices Type 10.3.1.1. Diagnostic Instruments 10.3.1.1.1. Probes 10.3.1.1.1.1. Single-Sided Probes 10.3.1.1.1.2. Double-Sided Probes 10.3.1.1.2. Mouth Mirrors 10.3.1.1.3. Explorers 10.3.1.2. Treatment Instruments 10.3.1.2.1. Scalers And curettes 10.3.1.2.2. Custom-Fit Trays 10.3.1.2.3. Cleansing and Polishing Instruments 10.3.1.2.4. Endoscopes 10.3.1.2.5. Dental Lasers 10.3.1.2.6. Dental Implants 10.3.1.2.6.1. Endosteal Implants 10.3.1.2.6.2. Subperiosteal Implants 10.3.1.3. Surgical Instruments 10.3.2. Drugs Type 10.3.2.1. Systemic Antibiotics 10.3.2.2. Local Antibiotics 10.4. Market Attractiveness Analysis, By Product 11. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Procedures 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ million) Analysis, By Procedures, 2015 to 2021 11.3. Current and Future Market Size (US$ million) Analysis and Forecast by Procedures, 2022 to 2032 11.3.1. Scaling And Root Planing 11.3.2. Gum Grafting 11.3.3. Regenerative Therapy 11.3.4. Dental Crown Lengthening 11.3.5. Pocket Procedures 11.3.6. Single Tooth Dental Implants 11.3.7. Multiple Tooth Dental Implants 11.4. Market Attractiveness Analysis, By Procedures 12. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ million) and Volume (Units), By End User, 2015 to 2021 12.3. Current and Future Market Size (US$ million) Forecast by End User, 2022 to 2032 12.3.1. Hospitals 12.3.2. Dental Clinics 12.3.3. Group Dental Practice 12.3.4. Ambulatory Surgical Centers 12.4. Market Attractiveness Analysis, By End User 13. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, by Region 13.1. Introduction 13.2. Historical Market Size (US$ million) and Volume (Units) Analysis, By Region, 2015 to 2021 13.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Region, 2022 to 2032 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. East Asia 13.3.5. South Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis, By Region 14. North America Market Analysis 2015 to 2021 and Forecast 2022 to 2032 14.1. Introduction 14.2. Historical Market Size (US$ million) and Volume (Units) Trend Analysis, By Market Taxonomy, 2015 to 2021 14.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032 14.3.1. By Country 14.3.1.1. The USA 14.3.1.2. Canada 14.3.2. By Product 14.3.3. By Procedures 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Procedures 14.4.4. By End User 14.5. Drivers and Restraints - Impact Analysis 14.6. Country-Level Analysis & Forecast 14.6.1. The USA Market Analysis 14.6.1.1. Introduction 14.6.1.2. Market Analysis and Forecast by Market Taxonomy 14.6.1.2.1. By Product 14.6.1.2.2. By Procedures 14.6.1.2.3. By End User 14.6.2. Canada Market Analysis 14.6.2.1. Introduction 14.6.2.2. Market Analysis and Forecast by Market Taxonomy 14.6.2.2.1. By Product 14.6.2.2.2. By Procedures 14.6.2.2.3. By End User 15. Latin America Market Analysis 2015 to 2021 and Forecast 2022 to 2032 15.1. Introduction 15.2. Historical Market Size (US$ million) and Volume (Units) Trend Analysis, By Market Taxonomy, 2015 to 2021 15.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032 15.3.1. By Country 15.3.1.1. Mexico 15.3.1.2. Brazil 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.2. By Product 15.3.3. By Procedures 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Procedures 15.4.4. By End User 15.5. Drivers and Restraints - Impact Analysis 15.6. Country Level Analysis & Forecast 15.6.1. Mexico Market Analysis 15.6.1.1. Introduction 15.6.1.2. Market Analysis and Forecast by Market Taxonomy 15.6.1.2.1. By Product 15.6.1.2.2. By Procedures 15.6.1.2.3. By End User 15.6.2. Brazil Market Analysis 15.6.2.1. Introduction 15.6.2.2. Market Analysis and Forecast by Market Taxonomy 15.6.2.2.1. By Product 15.6.2.2.2. By Procedures 15.6.2.2.3. By End User 15.6.3. Argentina Market Analysis 15.6.3.1. Introduction 15.6.3.2. Market Analysis and Forecast by Market Taxonomy 15.6.3.2.1. By Product 15.6.3.2.2. By Procedures 15.6.3.2.3. By End User 16. Europe Market Analysis 2015 to 2021 and Forecast 2022 to 2032 16.1. Introduction 16.2. Historical Market Size (US$ million) and Volume (Units) Trend Analysis, By Market Taxonomy, 2015 to 2021 16.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. Italy 16.3.1.3. France 16.3.1.4. The United Kingdom 16.3.1.5. Spain 16.3.1.6. Russia 16.3.1.7. BENELUX 16.3.1.8. Nordic Countries 16.3.1.9. Rest of Europe 16.3.2. By Product 16.3.3. By Procedures 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Procedures 16.4.4. By End User 16.5. Drivers and Restraints - Impact Analysis 16.6. Country-Level Analysis & Forecast 16.6.1. Germany Market Analysis 16.6.1.1. Introduction 16.6.1.2. Market Analysis and Forecast by Market Taxonomy 16.6.1.2.1. By Product 16.6.1.2.2. By Procedures 16.6.1.2.3. By End User 16.6.2. Italy Market Analysis 16.6.2.1. Introduction 16.6.2.2. Market Analysis and Forecast by Market Taxonomy 16.6.2.2.1. By Product 16.6.2.2.2. By Procedures 16.6.2.2.3. By End User 16.6.3. France Market Analysis 16.6.3.1. Introduction 16.6.3.2. Market Analysis and Forecast by Market Taxonomy 16.6.3.2.1. By Product 16.6.3.2.2. By Procedures 16.6.3.2.3. By End User 16.6.4. The United Kingdom Market Analysis 16.6.4.1. Introduction 16.6.4.2. Market Analysis and Forecast by Market Taxonomy 16.6.4.2.1. By Product 16.6.4.2.2. By Procedures 16.6.4.2.3. By End User 16.6.5. Spain Market Analysis 16.6.5.1. Introduction 16.6.5.2. Market Analysis and Forecast by Market Taxonomy 16.6.5.2.1. By Product 16.6.5.2.2. By Procedures 16.6.5.2.3. By End User 16.6.6. Russia Market Analysis 16.6.6.1. Introduction 16.6.6.2. Market Analysis and Forecast by Market Taxonomy 16.6.6.2.1. By Product 16.6.6.2.2. By Procedures 16.6.6.2.3. By End User 16.6.7. BENELUX Market Analysis 16.6.7.1. Introduction 16.6.7.2. Market Analysis and Forecast by Market Taxonomy 16.6.7.2.1. By Product 16.6.7.2.2. By Procedures 16.6.7.2.3. By End User 16.6.8. Nordic Countries Market Analysis 16.6.8.1. Introduction 16.6.8.2. Market Analysis and Forecast by Market Taxonomy 16.6.8.2.1. By Product 16.6.8.2.2. By Procedures 16.6.8.2.3. By End User 17. East Asia Market Analysis 2015 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.2. Historical Market Size (US$ million) and Volume (Units) Trend Analysis, By Market Taxonomy, 2015 to 2021 17.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Product 17.3.3. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Procedures 17.4.4. By End User 17.5. Drivers and Restraints - Impact Analysis 17.6. Country Level Analysis & Forecast 17.6.1. China Market Analysis 17.6.1.1. Introduction 17.6.1.2. Market Analysis and Forecast by Market Taxonomy 17.6.1.2.1. By Product 17.6.1.2.2. By Procedures 17.6.1.2.3. By End User 17.6.2. Japan Market Analysis 17.6.2.1. Introduction 17.6.2.2. Market Analysis and Forecast by Market Taxonomy 17.6.2.2.1. By Product 17.6.2.2.2. By Procedures 17.6.2.2.3. By End User 17.6.3. South Korea Market Analysis 17.6.3.1. Introduction 17.6.3.2. Market Analysis and Forecast by Market Taxonomy 17.6.3.2.1. By Product 17.6.3.2.2. By Procedures 17.6.3.2.3. By End User 18. South Asia Market Analysis 2015 to 2021 and Forecast 2022 to 2032 18.1. Introduction 18.2. Historical Market Size (US$ million) and Volume (Units) Trend Analysis, By Market Taxonomy, 2015 to 2021 18.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032 18.3.1. By Country 18.3.1.1. India 18.3.1.2. Indonesia 18.3.1.3. Malaysia 18.3.1.4. Thailand 18.3.1.5. Rest of South Asia 18.3.2. By Product 18.3.3. By Procedures 18.3.4. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Procedures 18.4.4. By End User 18.5. Drivers and Restraints - Impact Analysis 18.6. Country Level Analysis & Forecast 18.6.1. India Market Analysis 18.6.1.1. Introduction 18.6.1.2. Market Analysis and Forecast by Market Taxonomy 18.6.1.2.1. By Product 18.6.1.2.2. By Procedures 18.6.1.2.3. By End User 18.6.2. Indonesia Market Analysis 18.6.2.1. Introduction 18.6.2.2. Market Analysis and Forecast by Market Taxonomy 18.6.2.2.1. By Product 18.6.2.2.2. By Procedures 18.6.2.2.3. By End User 18.6.3. Malaysia Market Analysis 18.6.3.1. Introduction 18.6.3.2. Market Analysis and Forecast by Market Taxonomy 18.6.3.2.1. By Product 18.6.3.2.2. By Procedures 18.6.3.2.3. By End User 18.6.4. Thailand Market Analysis 18.6.4.1. Introduction 18.6.4.2. Market Analysis and Forecast by Market Taxonomy 18.6.4.2.1. By Product 18.6.4.2.2. By Procedures 18.6.4.2.3. By End User 19. Oceania Market 2015-2021 and Forecast 2022-2032 19.1. Introduction 19.2. Historical Market Size (US$ million) and Volume (Units) Trend Analysis, By Market Taxonomy, 2015 to 2021 19.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Product 19.3.3. By Procedures 19.3.4. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Procedures 19.4.4. By End User 19.5. Drivers and Restraints - Impact Analysis 19.6. Country Level Analysis & Forecast 19.6.1. Australia Market Analysis 19.6.1.1. Introduction 19.6.1.2. Market Analysis and Forecast by Market Taxonomy 19.6.1.2.1. By Product 19.6.1.2.2. By Procedures 19.6.1.2.3. By End User 19.6.2. New Zealand Market Analysis 19.6.2.1. Introduction 19.6.2.2. Market Analysis and Forecast by Market Taxonomy 19.6.2.2.1. By Product 19.6.2.2.2. By Procedures 19.6.2.2.3. By End User 20. Middle East and Africa (MEA) Market Analysis 2015 to 2021 and Forecast 2022 to 2032 20.1. Introduction 20.2. Historical Market Size (US$ million) and Volume (Units) Trend Analysis, By Market Taxonomy, 2015 to 2021 20.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. Turkey 20.3.1.3. South Africa 20.3.1.4. Rest of Middle East and Africa 20.3.2. By Product 20.3.3. By Procedures 20.3.4. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product 20.4.3. By Procedures 20.4.4. By End User 20.5. Drivers and Restraints - Impact Analysis 20.6. Country-Level Analysis & Forecast 20.6.1. GCC Countries Market Analysis 20.6.1.1. Introduction 20.6.1.2. Market Analysis and Forecast by Market Taxonomy 20.6.1.2.1. By Product 20.6.1.2.2. By Procedures 20.6.1.2.3. By End User 20.6.2. Turkey Market Analysis 20.6.2.1. Introduction 20.6.2.2. Market Analysis and Forecast by Market Taxonomy 20.6.2.2.1. By Product 20.6.2.2.2. By Procedures 20.6.2.2.3. By End User 20.6.3. South Africa Market Analysis 20.6.3.1. Introduction 20.6.3.2. Market Analysis and Forecast by Market Taxonomy 20.6.3.2.1. By Product 20.6.3.2.2. By Procedures 20.6.3.2.3. By End User 21. Market Structure Analysis 21.1. Market Analysis, By Tier of Companies 21.2. Market Share Analysis of Top Players 21.3. Market Presence Analysis 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep Dive 22.3.1. Acteon Group 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Key Financials 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.1.6. Key Developments 22.3.2. Dentsply Sirona 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Key Financials 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.2.6. Key Developments 22.3.3. 3M Company 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Key Financials 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.3.6. Key Developments 22.3.4. Danaher Corporation (Sybron Dental Specialties Inc./Kerr Corporation) 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Key Financials 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.4.6. Key Developments 22.3.5. Medtronic 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Key Financials 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.5.6. Key Developments 22.3.6. Pfizer Inc. 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Key Financials 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.6.6. Key Developments 22.3.7. Novartis AG 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Key Financials 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.7.6. Key Developments 22.3.8. ASA Dental S.p.A. 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Key Financials 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.8.6. Key Developments 22.3.9. Steris-Hu-Friedy 22.3.9.1. Overview 22.3.9.2. Product Portfolio 22.3.9.3. Key Financials 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.9.6. Key Developments 22.3.10. Carl MartinGmBH 22.3.10.1. Overview 22.3.10.2. Product Portfolio 22.3.10.3. Key Financials 22.3.10.4. Sales Footprint 22.3.10.5. Strategy Overview 22.3.10.6. Key Developments 22.3.11. Deppeler SA 22.3.11.1. Overview 22.3.11.2. Product Portfolio 22.3.11.3. Key Financials 22.3.11.4. Sales Footprint 22.3.11.5. Strategy Overview 22.3.11.6. Key Developments 22.3.12. AMD Lasers, Inc. 22.3.12.1. Overview 22.3.12.2. Product Portfolio 22.3.12.3. Key Financials 22.3.12.4. Sales Footprint 22.3.12.5. Strategy Overview 22.3.12.6. Key Developments 22.3.13. Biolase, Inc. 22.3.13.1. Overview 22.3.13.2. Product Portfolio 22.3.13.3. Key Financials 22.3.13.4. Sales Footprint 22.3.13.5. Strategy Overview 22.3.13.6. Key Developments 22.3.14. Straumann AG 22.3.14.1. Overview 22.3.14.2. Product Portfolio 22.3.14.3. Key Financials 22.3.14.4. Sales Footprint 22.3.14.5. Strategy Overview 22.3.14.6. Key Developments 22.3.15. Planmeca Oy 22.3.15.1. Overview 22.3.15.2. Product Portfolio 22.3.15.3. Key Financials 22.3.15.4. Sales Footprint 22.3.15.5. Strategy Overview 22.3.15.6. Key Developments 22.3.16. Karl Schumacher 22.3.16.1. Overview 22.3.16.2. Product Portfolio 22.3.16.3. Key Financials 22.3.16.4. Sales Footprint 22.3.16.5. Strategy Overview 22.3.16.6. Key Developments 22.3.17. GC Corporation 22.3.17.1. Overview 22.3.17.2. Product Portfolio 22.3.17.3. Key Financials 22.3.17.4. Sales Footprint 22.3.17.5. Strategy Overview 22.3.17.6. Key Developments 22.3.18. OraVu® 22.3.18.1. Overview 22.3.18.2. Product Portfolio 22.3.18.3. Key Financials 22.3.18.4. Sales Footprint 22.3.18.5. Strategy Overview 22.3.18.6. Key Developments 22.3.19. Micron Dental 22.3.19.1. Overview 22.3.19.2. Product Portfolio 22.3.19.3. Key Financials 22.3.19.4. Sales Footprint 22.3.19.5. Strategy Overview 22.3.19.6. Key Developments 22.3.20. DENTAURUM GmbH & Co. KG 22.3.20.1. Overview 22.3.20.2. Product Portfolio 22.3.20.3. Key Financials 22.3.20.4. Sales Footprint 22.3.20.5. Strategy Overview 22.3.20.6. Key Developments 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports